Literature DB >> 18702969

Pharmacogenomics and the failing heart are we waiting for godot?

Douglas L Mann, Dennis M McNamara.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18702969      PMCID： PMC2563958          DOI： 10.1016/j.jacc.2008.05.023

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  8 in total

Review 1.  Mechanisms and models in heart failure: the biomechanical model and beyond.

Authors:  Douglas L Mann; Michael R Bristow
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

Review 2.  Pharmacogenetics of beta-blockers.

Authors:  Jaekyu Shin; Julie A Johnson
Journal:  Pharmacotherapy       Date:  2007-06       Impact factor: 4.705

3.  Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.

Authors:  Amy J Sehnert; Susan E Daniels; Michael Elashoff; James A Wingrove; Christopher R Burrow; Benjamin Horne; Joseph B Muhlestein; Mark Donahue; Stephen B Liggett; Jeffrey L Anderson; William E Kraus
Journal:  J Am Coll Cardiol       Date:  2008-06-23       Impact factor: 24.094

4.  Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure.

Authors:  Kersten M Small; Lynne E Wagoner; Albert M Levin; Sharon L R Kardia; Stephen B Liggett
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

5.  A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.

Authors:  Stephen B Liggett; Jeanne Mialet-Perez; Surai Thaneemit-Chen; Stewart A Weber; Scott M Greene; Danielle Hodne; Bradley Nelson; Jennifer Morrison; Michael J Domanski; Lynne E Wagoner; William T Abraham; Jeffrey L Anderson; John F Carlquist; Heidi J Krause-Steinrauf; Laura C Lazzeroni; J David Port; Philip W Lavori; Michael R Bristow
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-14       Impact factor: 11.205

6.  An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study.

Authors:  Hazel L White; Rudolf A de Boer; Azhar Maqbool; Darren Greenwood; Dirk J van Veldhuisen; Richard Cuthbert; Stephen G Ball; Alistair S Hall; Anthony J Balmforth
Journal:  Eur J Heart Fail       Date:  2003-08       Impact factor: 15.534

7.  Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.

Authors:  Dennis M McNamara; Richard Holubkov; Lisa Postava; Karen Janosko; Guy A MacGowan; Michael Mathier; Srinivas Murali; Arthur M Feldman; Barry London
Journal:  J Am Coll Cardiol       Date:  2004-11-16       Impact factor: 24.094

Review 8.  Role of beta adrenergic receptor polymorphisms in heart failure: systematic review and meta-analysis.

Authors:  Amal Muthumala; Fotios Drenos; Perry M Elliott; Steve E Humphries
Journal:  Eur J Heart Fail       Date:  2007-12-26       Impact factor: 15.534
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.